Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer. [electronic resource]
Producer: 20161213Description: 1124-30 p. digitalISSN:- 1976-2437
- Adenocarcinoma -- drug therapy
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Erlotinib Hydrochloride -- administration & dosage
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Male
- Middle Aged
- Neoplasm Staging
- Pancreatic Neoplasms -- drug therapy
- Retrospective Studies
- Survival Rate
- Young Adult
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.